» Articles » PMID: 36694588

SARS-CoV-2 Vaccines: What We Know, What We Can Do to Improve Them and What We Could Learn from Other Well-known Viruses

Overview
Journal AIMS Microbiol
Specialty Microbiology
Date 2023 Jan 25
PMID 36694588
Authors
Affiliations
Soon will be listed here.
Abstract

In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the globe, even in countries where vaccination programs have been strongly implemented. In these regions in 2021, a reduction in the number of hospitalizations and deaths compared to 2020 was observed. This decrease is certainly associated with the introduction of vaccination measures. The process of the development of effective vaccines represents an important challenge. Overall, the breakthrough infections occurring in vaccinated subjects are in most cases less severe than those observed in unvaccinated individuals. This review examines the factors affecting the immunogenicity of vaccines against SARS-CoV-2 and the possible role of nutrients in modulating the response of distinct immune cells to the vaccination.

References
1.
Fiorino S, Tateo F, de Biase D, Gallo C, Orlandi P, Corazza I . SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol. 2021; 16:1105-1133. PMC: 8412036. DOI: 10.2217/fmb-2021-0064. View

2.
Surman S, Penkert R, Jones B, Sealy R, Hurwitz J . Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D. Clin Vaccine Immunol. 2016; 23(3):219-27. PMC: 4783424. DOI: 10.1128/CVI.00739-15. View

3.
Latif M, Shukla S, Del Rio Estrada P, Pereira Ribeiro S, Sekaly R, Sharma A . Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection. Transl Res. 2021; 241:83-95. PMC: 8641406. DOI: 10.1016/j.trsl.2021.12.001. View

4.
Gazit S, Mizrahi B, Kalkstein N, Neuberger A, Peretz A, Mizrahi-Reuveni M . BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 Patients. Clin Infect Dis. 2021; 75(1):e734-e740. PMC: 8767821. DOI: 10.1093/cid/ciab973. View

5.
Chiang N, Serhan C . Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem. 2020; 64(3):443-462. PMC: 7682745. DOI: 10.1042/EBC20200018. View